Guidelines for Project Presentation
- All group members must participate in the presentation
- Each presentation should last about 5 minutes to make their presentation and 2 minutes to answer questions. Time limits will be strictly enforced to make sure all groups get the same amount of time. If you exceed 6 minutes, you will be asked to stop and be evaluated on what has been presented to that point. Practice your presentation. Remember that you can always read it faster to yourself than you can out loud and nervous. Also, have someone in your group track your time. If you are presenting alone, ask someone in another group to give you time cues.
- Presentations need to be in PowerPoint format and recorded on a CD-ROM or a USB key. Be sure that the file opens on any computer by trying to open it on several different machines.
- The audience for your presentation will be a scientific review panel from the World Health Organization. The panel will review the proposed designs and decide which efforts will receive funding to move into the development phase. Therefore, you must convince the panel of the severity of the problem as well as the efficacy of the proposed design. Your prototype does not need to actually function, but it should illustrate the scientific principles of the device as well as the ways in which it satisfies the design requirements. In constructing your prototype, we suggest that you use common household materials (plastic wrap, aluminum foil, cardboard, etc) to illustrate how the device would work. You are limited to a total materials cost of $10 and you will be asked to turn in receipts to verify that you satisfied this constraint. You should be prepared for questions from the review panel following your 10 minute presentation.
- You will evaluate each presentation using the attached form. Please note that you may only recommend TWO DESIGNS for further development.
Presentation Group No./Room Number/Evaluator / # / Group Members / Disease/Disorder / Treatment/Technology
Jair
Stephanie
Yvette
Keck Hall 100 / 1 / Ivy Kuperberg
Rory Bledsoe / Type 1 Diabetes / Information Technology
2 / Erica Han
Shinhae Lee
Paul Maliakkal / Obesity / Education and funding program
3 / Schuyler Woods
Yordanos Gebretatios / Obstetric Fistula / New diagnostic tool
4 / Sarah Taylor
Kathleen Hanson / Sickle Cell Disease / Screening device
5 / Alex Gordon
Ginny Stuckey
Eric Vu
Peter Yang / Osteoporosis / Medical device to limit bone density loss
6 / Josh Hesterman
Kathleen Shergy
Jason Altobelli / Japanese Encephalitis
7 / Myra D’Souza
Anushree Kumar
Neel Srikishen / Lymphatic Filariasis
8 / Teresa Monkkonen
Joe Mendez
Nancy O’Connor / Chagas Disease
9 / Vincent Malouf / Lymphatic Filariasis
10 / Gary Johnson
Sara Slabisak
Zach Dreyfuss / Schistosomiasis
Presentation Group No./Room Number/Evaluator / # / Group Members / Disease/Disorder / Treatment/Technology
Ryan
Darren
Dr. RRK
Keck Hall 102 / 11 / Julia Ridgeway
Mia Lopez
Rachelle Sam
Jeremy Tullis / TB / Medication patch
12 / Anjuli Shivshanker
Natalie Gwilliam
Emmma Johns / TB / Color change indicator for dosing
13 / Shuvro De
Natalie Vasco
Samantha Hong / Meningitis / IM drug injection
14 / Kassaundra Esculera
Nydia Trevino
Jackie Kirby / Leprosy / New optical detection method
15 / Jesdeep Mangat
Ponney Palanisamy
Lindsay Zwiener / TB / Social policy change
16 / Anne Hierholzer
Marissa Eubanks
Renata Medina / TB / DOT enhancement
17 / Nikki Metzgar
Mara Courtney
Ingrid Norbergs
Bailey Rodriguez / HPV / Push for HPV Vaccine
18 / Jose Sanchez
Johanna Andrews-Chavez
Gislaine Williams
Meagan Barry / Dengue / Mosquito net improvements
19 / Rachel Lattimore
Priti Dangayach
Christina Lagos / Dengue / Mosquito net improvements
20 / Andrew Bowen
Kirsub Choe
Sarah Conlon
Justin Hudson / Ebola / Sterilized Kit
Evaluation Form:
You are a member of a scientific review panel from the World Health Organization. Your job is to review the proposed designs and decide which efforts will receive funding to move into the development phase. Please evaluate each proposal using the criteria below. You may only recommend two designs to receive funding.
Name of Evaluator:
Group Number:
Disease:
Diagnosis/Treatment:
Severity of the problem:
12345678910
Minor health problemUrgent unmet health need
Efficacy of the proposed design:
12345678910
Solution does not address at least one major constraintSolution satisfies design constraints
Not economically feasible in proposed settingLikely to be safe, effective, and cost-effective
Quality of the presentation:
12345678910
Difficult to followCompelling presentation
Poor quality demoDemo illustrates technical principles
Overall Recommendation:
12345678910
Do not consider furtherWorthy of future considerationDefinitely fund
but not yet ready for funding
Comments: